Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determination of the 50% and 95% Effective Dose of Remimazolam for Intravenous Anesthesia Induction in Pediatric Patients

NCT05990673 is registered in ClinicalTrials.gov with Zhihong LU as lead sponsor.

NCT NCT05990673
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05990673 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determination of the 50% and 95% Effective Dose of Remimazolam for Intravenous Anesthesia Induction in Pediatric Patients
Lead sponsor
Zhihong LU
Phase
Not applicable
Overall status
Unknown status
Start date
August 10, 2023
Completion date
September 10, 2023
Enrollment
25 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia